Clinical Trials Arena on MSN
Novo Nordisk reports Phase II data for zenagamtide in diabetes
The primary endpoint, change in HbA1C after 36 weeks, was met at all doses.
OpenAI is preparing what CNBC’s Joe Kernen, citing Financial Times reporting, called “The biggest update to ChatGPT since the ...
Clofutriben improved HbA1c and other cardiometabolic parameters in patients with Type 2 diabetes in a 6-week, ...
SHELTON, CT / ACCESS Newswire / June 8, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, NanoViricides ...
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...
Vietnam Investment Review on MSN
OriCell s GPC3 CAR T therapy Ori C101 receives NMPA clearance for Phase II liver cancer trial
SHANGHAI, June 8, 2026 /PRNewswire/ -- OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , announced that its proprietary GPC3-targeted autologous CAR-T therapy, Ori-C101, has ...
Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial ...
Use Attack Drone is part of the next generation of American-built one-way attack drones Powerus recently announced a ...
Fluor announced that its JGC Fluor BC LNG II joint venture with JGC Corporation (JFJV2) has received limited notice to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results